| Literature DB >> 12057112 |
Abstract
The only definitive therapy for patients with pheochromocytoma is surgical resection [1,2**]. Advances in preoperative medical management of hypertension/hypovolemia and improved intraoperative anesthetic care have reduced the operative mortality rate for pheochromocytoma to less than 5% in most series. In addition, accurate preoperative localization studies have eliminated the need for extensive exploratory laparotomy. Focused approach and laparoscopic resection have become the new "gold standard," with a reduced morbidity [4**]. Large or locally invasive pheochromocytomas may still require open resection.Entities:
Mesh:
Substances:
Year: 2001 PMID: 12057112 DOI: 10.1007/s11864-001-0025-5
Source DB: PubMed Journal: Curr Treat Options Oncol ISSN: 1534-6277